Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Relationship between estimated glomerular filtration rate, albuminuria, and oxidant status in the Japanese population

Authors: Yuko Ishizaka, Minoru Yamakado, Akiko Toda, Mizuki Tani, Nobukazu Ishizaka

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

In the general population, reported levels of oxidative stress and antioxidant potential seem to vary. The aim of this study was to investigate the levels of oxidant status markers in relation to estimated glomerular filtration rate (eGFR) and albuminuria in Japanese population.

Methods

Data were analyzed from 8335 individuals who underwent a general health screening test. For the estimation of albuminuria, urinary albumin-to-creatinine ratio (UAER) was calculated. Oxidant status was determined by assessing derivatives of reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP).

Results

After adjusting for age, high blood pressure, depressor agent use, CRP, smoking status, multivariate logistic regression analysis showed that the lowest eGFR quartile was associated negatively with the top d-ROM quartile in men (odds ratio 0.78 [95% CI 0.62-0.98, P = 0.034]) and the highest UAER was associated with the top d-ROM in men (odds ratio 1.68) [95% CI 1.35-2.10, P < 0.001]. In addition, both the first eGFR quartile and the fourth UAER quartile showed significant positive association with low BAP levels in men, but not in women.

Conclusions

Among men who underwent general health screening, lower eGFR and increased albuminuria was negatively and positively, respectively, associated with higher oxidative stress levels, whereas both conditions were positively associated with lower antioxidant potential levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kearns B, Gallagher H, De Lusignan S: Predicting the prevalence of chronic kidney disease in the english population: a cross-sectional study. BMC Nephrol. 2013, 14: 49-10.1186/1471-2369-14-49.CrossRefPubMedPubMedCentral Kearns B, Gallagher H, De Lusignan S: Predicting the prevalence of chronic kidney disease in the english population: a cross-sectional study. BMC Nephrol. 2013, 14: 49-10.1186/1471-2369-14-49.CrossRefPubMedPubMedCentral
2.
go back to reference Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y: Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama study. Nephrol Dial Transplant. 2010, 25 (8): 2557-2564. 10.1093/ndt/gfq062.CrossRefPubMed Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y: Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama study. Nephrol Dial Transplant. 2010, 25 (8): 2557-2564. 10.1093/ndt/gfq062.CrossRefPubMed
3.
go back to reference Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, et al: Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013, 61 (6): 930-938. 10.1053/j.ajkd.2013.01.018.CrossRefPubMedPubMedCentral Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, et al: Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013, 61 (6): 930-938. 10.1053/j.ajkd.2013.01.018.CrossRefPubMedPubMedCentral
4.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351 (13): 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351 (13): 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed
5.
go back to reference Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, et al: Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012, 308 (22): 2349-2360. 10.1001/jama.2012.16817.CrossRefPubMedPubMedCentral Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, et al: Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012, 308 (22): 2349-2360. 10.1001/jama.2012.16817.CrossRefPubMedPubMedCentral
6.
go back to reference Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 2004, 13 (1): 93-99. 10.1097/00041552-200401000-00013.CrossRefPubMed Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 2004, 13 (1): 93-99. 10.1097/00041552-200401000-00013.CrossRefPubMed
7.
go back to reference Ruiz S, Pergola PE, Zager RA, Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013, 83 (6): 1029-1041. 10.1038/ki.2012.439.CrossRefPubMedPubMedCentral Ruiz S, Pergola PE, Zager RA, Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013, 83 (6): 1029-1041. 10.1038/ki.2012.439.CrossRefPubMedPubMedCentral
8.
go back to reference Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM: Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2008, 28 (3): 397-404. 10.1159/000112413.CrossRefPubMed Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM: Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2008, 28 (3): 397-404. 10.1159/000112413.CrossRefPubMed
9.
go back to reference Kim HJ, Vaziri ND: Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010, 298 (3): F662-F671. 10.1152/ajprenal.00421.2009.CrossRefPubMed Kim HJ, Vaziri ND: Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010, 298 (3): F662-F671. 10.1152/ajprenal.00421.2009.CrossRefPubMed
10.
go back to reference Dupont JJ, Farquhar WB, Townsend RR, Edwards DG: Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol. 2011, 111 (6): 1561-1567. 10.1152/japplphysiol.00419.2011.CrossRefPubMedPubMedCentral Dupont JJ, Farquhar WB, Townsend RR, Edwards DG: Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol. 2011, 111 (6): 1561-1567. 10.1152/japplphysiol.00419.2011.CrossRefPubMedPubMedCentral
11.
go back to reference Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T: The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res. 2012, 27 (2): 474-485. 10.1002/jbmr.539.CrossRefPubMed Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T: The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res. 2012, 27 (2): 474-485. 10.1002/jbmr.539.CrossRefPubMed
12.
go back to reference Fukui T, Yamauchi K, Maruyama M, Yasuda T, Kohno M, Abe Y: Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertens Res. 2011, 34 (9): 1041-1045. 10.1038/hr.2011.76.CrossRefPubMed Fukui T, Yamauchi K, Maruyama M, Yasuda T, Kohno M, Abe Y: Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertens Res. 2011, 34 (9): 1041-1045. 10.1038/hr.2011.76.CrossRefPubMed
13.
go back to reference Ishizaka Y, Yamakado M, Toda A, Tani M, Ishizaka N: Relationship between coffee consumption, oxidant status, and antioxidant potential in the Japanese general population. Clin Chem Lab Med. 2013, (in press) doi: 10.1515/cclm-2013-0146 Ishizaka Y, Yamakado M, Toda A, Tani M, Ishizaka N: Relationship between coffee consumption, oxidant status, and antioxidant potential in the Japanese general population. Clin Chem Lab Med. 2013, (in press) doi: 10.1515/cclm-2013-0146
14.
go back to reference Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005, 25 (5): 1038-1044. 10.1161/01.ATV.0000161274.87407.26.CrossRefPubMed Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005, 25 (5): 1038-1044. 10.1161/01.ATV.0000161274.87407.26.CrossRefPubMed
15.
go back to reference Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A: A simple test to monitor oxidative stress. Int Angiol. 1999, 18 (2): 127-130.PubMed Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A: A simple test to monitor oxidative stress. Int Angiol. 1999, 18 (2): 127-130.PubMed
16.
go back to reference Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb. 2009, 16 (2): 77-82. 10.5551/jat.E265.CrossRefPubMed Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb. 2009, 16 (2): 77-82. 10.5551/jat.E265.CrossRefPubMed
17.
go back to reference Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996, 239 (1): 70-76. 10.1006/abio.1996.0292.CrossRefPubMed Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996, 239 (1): 70-76. 10.1006/abio.1996.0292.CrossRefPubMed
18.
go back to reference Dohi K, Satoh K, Ohtaki H, Shioda S, Miyake Y, Shindo M, Aruga T: Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo. 2005, 19 (5): 855-860.PubMed Dohi K, Satoh K, Ohtaki H, Shioda S, Miyake Y, Shindo M, Aruga T: Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo. 2005, 19 (5): 855-860.PubMed
19.
go back to reference Kamezaki F, Yamashita K, Kubara T, Suzuki Y, Tanaka S, Rkouzuma R, Okazaki M, Tasaki H, Otuji Y: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb. 2008, 15 (4): 206-212. 10.5551/jat.E538.CrossRefPubMed Kamezaki F, Yamashita K, Kubara T, Suzuki Y, Tanaka S, Rkouzuma R, Okazaki M, Tasaki H, Otuji Y: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb. 2008, 15 (4): 206-212. 10.5551/jat.E538.CrossRefPubMed
20.
go back to reference Pasquini A, Luchetti E, Marchetti V, Cardini G, Iorio EL: Analytical performances of d-ROMs test and BAP test in canine plasma: definition of the normal range in healthy labrador dogs. Vet Res Commun. 2008, 32 (2): 137-143. 10.1007/s11259-007-9014-x.CrossRefPubMed Pasquini A, Luchetti E, Marchetti V, Cardini G, Iorio EL: Analytical performances of d-ROMs test and BAP test in canine plasma: definition of the normal range in healthy labrador dogs. Vet Res Commun. 2008, 32 (2): 137-143. 10.1007/s11259-007-9014-x.CrossRefPubMed
21.
go back to reference Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001, 131 (12): 3208-3211.PubMed Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001, 131 (12): 3208-3211.PubMed
22.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009, 53 (6): 982-992. 10.1053/j.ajkd.2008.12.034.CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009, 53 (6): 982-992. 10.1053/j.ajkd.2008.12.034.CrossRefPubMed
23.
go back to reference Nerpin E, Helmersson-Karlqvist J, Riserus U, Sundstrom J, Larsson A, Jobs E, Basu S, Ingelsson E, Arnlov J: Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study. BMC Res Notes. 2012, 5: 537-10.1186/1756-0500-5-537.CrossRefPubMedPubMedCentral Nerpin E, Helmersson-Karlqvist J, Riserus U, Sundstrom J, Larsson A, Jobs E, Basu S, Ingelsson E, Arnlov J: Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study. BMC Res Notes. 2012, 5: 537-10.1186/1756-0500-5-537.CrossRefPubMedPubMedCentral
24.
go back to reference Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O’Donnell CJ, Kathiresan S, Meigs JB, Keaney JF, Rong J, et al: Inflammation, kidney function and albuminuria in the Framingham offspring cohort. Nephrol Dial Transplant. 2011, 26 (3): 920-926. 10.1093/ndt/gfq471.CrossRefPubMed Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O’Donnell CJ, Kathiresan S, Meigs JB, Keaney JF, Rong J, et al: Inflammation, kidney function and albuminuria in the Framingham offspring cohort. Nephrol Dial Transplant. 2011, 26 (3): 920-926. 10.1093/ndt/gfq471.CrossRefPubMed
25.
go back to reference Halliwell B, Lee CY: Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal. 2010, 13 (2): 145-156. 10.1089/ars.2009.2934.CrossRefPubMed Halliwell B, Lee CY: Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal. 2010, 13 (2): 145-156. 10.1089/ars.2009.2934.CrossRefPubMed
26.
go back to reference Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004, 65 (3): 1009-1016. 10.1111/j.1523-1755.2004.00465.x.CrossRefPubMed Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004, 65 (3): 1009-1016. 10.1111/j.1523-1755.2004.00465.x.CrossRefPubMed
27.
go back to reference Rebholz CM, Wu T, Hamm LL, Arora R, Khan IE, Liu Y, Chen CS, Mills KT, Rogers S, Kleinpeter MA, et al: The association of plasma fluorescent oxidation products and chronic kidney disease: a case–control study. Am J Nephrol. 2012, 36 (4): 297-304. 10.1159/000342330.CrossRefPubMedPubMedCentral Rebholz CM, Wu T, Hamm LL, Arora R, Khan IE, Liu Y, Chen CS, Mills KT, Rogers S, Kleinpeter MA, et al: The association of plasma fluorescent oxidation products and chronic kidney disease: a case–control study. Am J Nephrol. 2012, 36 (4): 297-304. 10.1159/000342330.CrossRefPubMedPubMedCentral
28.
go back to reference Rashidi A, Nakhjavani M, Esteghamati A, Asgarani F, Khalilzadeh O, Abbasi M, Safari R: Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients. J Nephrol. 2009, 22 (6): 733-738.PubMed Rashidi A, Nakhjavani M, Esteghamati A, Asgarani F, Khalilzadeh O, Abbasi M, Safari R: Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients. J Nephrol. 2009, 22 (6): 733-738.PubMed
29.
go back to reference Prior SL, Tang TS, Gill GV, Bain SC, Stephens JW: Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “golden years” type 1 diabetes mellitus cohort. Metabolism. 2011, 60 (2): 173-179. 10.1016/j.metabol.2009.12.008.CrossRefPubMed Prior SL, Tang TS, Gill GV, Bain SC, Stephens JW: Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “golden years” type 1 diabetes mellitus cohort. Metabolism. 2011, 60 (2): 173-179. 10.1016/j.metabol.2009.12.008.CrossRefPubMed
30.
go back to reference Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E, Akiyama Y, Toyohara T, Suzuki T, Tanemoto M, et al: Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J Am Soc Nephrol. 2011, 22 (4): 635-648. 10.1681/ASN.2009111130.CrossRefPubMedPubMedCentral Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E, Akiyama Y, Toyohara T, Suzuki T, Tanemoto M, et al: Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. J Am Soc Nephrol. 2011, 22 (4): 635-648. 10.1681/ASN.2009111130.CrossRefPubMedPubMedCentral
31.
go back to reference Takao T, Horino T, Kagawa T, Matsumoto R, Inoue K, Taguchi T, Morita T, Iwasaki Y, Hashimoto K, Terada Y: Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells. Am J Nephrol. 2009, 29 (2): 102-108. 10.1159/000151294.CrossRefPubMed Takao T, Horino T, Kagawa T, Matsumoto R, Inoue K, Taguchi T, Morita T, Iwasaki Y, Hashimoto K, Terada Y: Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells. Am J Nephrol. 2009, 29 (2): 102-108. 10.1159/000151294.CrossRefPubMed
32.
go back to reference Kostapanos MS, Spyrou AT, Tellis CC, Gazi IF, Tselepis AD, Elisaf M, Liberopoulos EN: Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids. 2011, 46 (4): 341-348. 10.1007/s11745-011-3539-z.CrossRefPubMed Kostapanos MS, Spyrou AT, Tellis CC, Gazi IF, Tselepis AD, Elisaf M, Liberopoulos EN: Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids. 2011, 46 (4): 341-348. 10.1007/s11745-011-3539-z.CrossRefPubMed
Metadata
Title
Relationship between estimated glomerular filtration rate, albuminuria, and oxidant status in the Japanese population
Authors
Yuko Ishizaka
Minoru Yamakado
Akiko Toda
Mizuki Tani
Nobukazu Ishizaka
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-191

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.